Amgen Financial Diagnostics

Amgen Inc -- USA Stock  

USD 186.64  0.88  0.47%

Amgen Inc diagnostics interface makes it easy to digest most current publicly released information about Amgen as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Amgen price relationship with some important fundamental indicators such as market cap and management efficiency.
About 80.0% of the company shares are held by institutions such as insurance companies. Book value of Amgen Inc was presently as 43.41. The company recorded earning per share (EPS) of 10.98. Amgen Inc last dividend was issued on 2017-08-15. This company had 2:1 split on 1999-11-22. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. For more info on AMGEN please contact Robert Bradway at 805 447-1010 or go to www.amgen.com.

Amgen Inc Alerts

Amgen Inc has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 80.0% of the company shares are held by institutions such as insurance companies
On August 15, 2017 Amgen paid $ 1.15 per share dividend to its current shareholders
Latest headline from MacroaxisInsider: Amgen exotic insider transaction detected

Amgen Inc Upcoming Events

Upcoming Quarterly ReportApril 27, 2017
Next Earnings ReportJuly 26, 2017

Amgen Inc EPS Estimate

EPSEstimate Date
Quarterly Estimate2.99April 27, 2017

Amgen SEC Filings

Financial Statements and Exhibits. Results of Operations and Financial Condition
Unclassified Corporate Event
Unclassified Corporate Event
Unclassified Corporate Event
Departure of Directors or Certain Offices; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Unclassified Corporate Event
Financial Statements and Exhibits. Results of Operations and Financial Condition
Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement

Institutional Investors

Security TypeSharesValue
Fmr LlcCommon Shares57 M9.8 B
Capital Research Global InvestorsCommon Shares53.7 M9.3 B
Vanguard Group IncCommon Shares52.1 M9 B
Blackrock IncCommon Shares49.5 M8.5 B
State Street CorpCommon Shares33 M5.7 B
Primecap Management CoCommon Shares23 M4 B
Northern Trust CorpCommon Shares9.3 M1.6 B

Market Capitalization

The company currently falls under 'Mega-Cap' category with current market capitalization of 136.06 B.

Profitablity

The company has Profit Margin (PM) of 35.46 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 44.49 % which suggests for every 100 dollars of sales it generated a net operating income of 0.44.

Management Efficiency

Amgen Inc has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.

Stock Holders for Amgen

Information
Ratio
Value
At Risk
NASDAQ NNASDAQ N America Large Mid Cap(0.35) (1.29) 
NasdaqNasdaq(0.007800) (0.59) 
AmericanAmerican Funds Capital World GrInc A 0.040000 (0.53) 
AmericanAmerican Funds Capital World GrInc R5 0.037200 (0.59) 
Nasdaq USNasdaq US Shareholder Yield Net 0.12 (0.49) 
AmericanAmerican Funds American Mutual R5E 0.037900 (0.32) 
BairdBaird LargeCap Inst 0.19 (0.10) 
VYVY Templeton Global Growth A 0.14 (0.29) 
OldOld Mutual Global Equity Inc A USD Inc(0.15) (0.62) 
KnightsKnights of Columbus Large Cap V 0.086100 (0.36) 
CNLSXCastlemaine LongShort 0.15 (0.60) 
CGSLXClearbridge Global Health Care 0.15 (0.66) 
NuveenNuveen Large Cap Value A 0.13 (0.62) 
AllianzGIAllianzGI Health Sciences A 0.087800 (0.62) 
FidelityFidelity Trend(0.005700) (0.49) 
CommerceCommerce Value 0.052100 (0.34) 
FidelityFidelity Advisor Health Care M 0.090300 (0.74) 
AB AllAB All Market Alternative Return Adv(0.42) (0.60) 
JSGRXJHancock Strategic Growth R2(0.013000) (0.47) 
db xdb x trackers MSCI Wld Hlth Care 1C(0.031100) (0.72) 

Technical Drivers

Amgen Inc shows Mean Deviation of 0.9094 and Risk Adjusted Performance of 0.15. Amgen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found eighteen technical drivers for Amgen Inc which can be compared to its rivals. Please confirm Amgen Inc Variance as well as the relationship between Maximum Drawdown and Semi Variance to decide if Amgen Inc is priced correctly providing market reflects its regular price of 186.64 per share. Given that Amgen has Treynor Ratio of 0.245, we suggest you validate Amgen Inc prevailing market performance to make sure the company can sustain itself at future point.

Bonds

Amgen Outstanding Bonds
MaturityCouponRating
031162AA8 8.125%04/01/20978.125
A
031162AV2 5.85%06/01/20175.85
A
031162AW0 6.375%06/01/20376.375
A
031162AX8 6.15%06/01/20186.15
A
031162AY6 6.9%06/01/20386.9
A
031162AZ3 5.7%02/01/20195.7
A
031162BA7 6.4%02/01/20396.4
A
031162BB5 4.5%03/15/20204.5
A
031162BC3 5.75%03/15/20405.75
A
031162BD1 3.45%10/01/20203.45
A
031162BE9 4.95%10/01/20414.95
A
031162BF6 2.3%06/15/20162.3
A
031162BG4 4.1%06/15/20214.1
A
031162BH2 5.65%06/15/20425.65
A
031162BK5 5.15%11/15/20415.15
A
031162BL3 2.5%11/15/20162.5
A
031162BM1 3.875%11/15/20213.875
A
031162BN9 3.625%05/15/20223.625
A
031162BP4 5.375%05/15/20435.375
A
031162BQ2 2.125%05/15/20172.125
A
031162BR0 1.25%05/22/20171.25
A
031162BU3 2.2%05/22/20192.2
A
031162BV1 3.625%05/22/20243.625
A
031162AS9 5.85%06/01/20175.85
A
031162BW9 2.125%05/01/20202.125
NA
031162BX7 2.7%05/01/20222.7
A
031162BY5 3.125%05/01/20253.125
A
031162BZ2 4.4%05/01/20454.4
A

Corporate Filings

Amgen Corporate Reports
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations